ICAP

This is a continuing project

HPTN 067: Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (The ADAPT Study)

HPTN 067: Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (The ADAPT Study)Districts (or national)Harlem

Project Details

The ADAPT Study recruited men who have sex with men (MSM) and transgender women and was designed to identify oral pre-exposure prophylaxis (PrEP) pill-taking schedules that participants are more likely to follow and determine if these schedules influence healthier sexual practices. (funded by NIH) Report Links: Mannheimer, et. al. 2019. Factors associated with sex-related pre-exposure prophylaxis adherence among men who have sex with men (MSM) in New York City in HPTN 067. JAIDS. Franks, et. al. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS and Behavior. Web Links: https://clinicaltrials.gov/ct2/show/NCT01327651